Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102932795 | 10293279 | 5 | F | 2005 | 20160829 | 20140710 | 20160831 | EXP | US-GLAXOSMITHKLINE-A0874665A | GLAXOSMITHKLINE | 68.20 | YR | F | Y | 0.00000 | 20160831 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102932795 | 10293279 | 1 | PS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 100/50 INCREASED TO 250/50 AND THEN 500/50 | U | UNKNOWN | 21077 | 1 | DF | INHALATION POWDER | BID | ||||
| 102932795 | 10293279 | 2 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 250/50 UG | U | 21077 | INHALATION POWDER | |||||||||
| 102932795 | 10293279 | 3 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 1 PUFF(S), QD, 500/50 UG | U | 5ZP8689 | 21077 | 1 | DF | INHALATION POWDER | QD | |||||
| 102932795 | 10293279 | 4 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 100/50 UG | U | UNKNOWN | 21077 | INHALATION POWDER | ||||||||
| 102932795 | 10293279 | 5 | SS | SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | Unknown | U | 0 | ||||||||||
| 102932795 | 10293279 | 6 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | TABLET | U | 0 | |||||||||
| 102932795 | 10293279 | 7 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | U | 0 | |||||||||||
| 102932795 | 10293279 | 8 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | U | 0 | |||||||||||
| 102932795 | 10293279 | 9 | C | URSODIOL. | URSODIOL | 1 | U | 0 | |||||||||||
| 102932795 | 10293279 | 10 | C | ECOTRIN | ASPIRIN | 1 | U | 0 | |||||||||||
| 102932795 | 10293279 | 11 | C | XANAX | ALPRAZOLAM | 1 | U | 0 | |||||||||||
| 102932795 | 10293279 | 12 | C | KLONOPIN | CLONAZEPAM | 1 | U | 0 | |||||||||||
| 102932795 | 10293279 | 13 | C | CLONIDINE. | CLONIDINE | 1 | U | 0 | |||||||||||
| 102932795 | 10293279 | 14 | C | XOPENEX | LEVALBUTEROL HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 102932795 | 10293279 | 15 | C | ZITHROMAX | AZITHROMYCIN DIHYDRATE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102932795 | 10293279 | 1 | Chronic obstructive pulmonary disease |
| 102932795 | 10293279 | 2 | Asthma |
| 102932795 | 10293279 | 3 | Bronchitis |
| 102932795 | 10293279 | 5 | Product used for unknown indication |
| 102932795 | 10293279 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102932795 | 10293279 | HO |
| 102932795 | 10293279 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102932795 | 10293279 | Adverse event | |
| 102932795 | 10293279 | Angioplasty | |
| 102932795 | 10293279 | Asthenia | |
| 102932795 | 10293279 | Biliary cirrhosis | |
| 102932795 | 10293279 | Carbon dioxide abnormal | |
| 102932795 | 10293279 | Central venous catheter removal | |
| 102932795 | 10293279 | Chronic obstructive pulmonary disease | |
| 102932795 | 10293279 | Colectomy | |
| 102932795 | 10293279 | Colon cancer | |
| 102932795 | 10293279 | Device occlusion | |
| 102932795 | 10293279 | Drug ineffective | |
| 102932795 | 10293279 | Dyspnoea | |
| 102932795 | 10293279 | Dyspnoea exertional | |
| 102932795 | 10293279 | Gastroenteritis norovirus | |
| 102932795 | 10293279 | Haemophilus infection | |
| 102932795 | 10293279 | Hepatic failure | |
| 102932795 | 10293279 | Hospitalisation | |
| 102932795 | 10293279 | Ill-defined disorder | |
| 102932795 | 10293279 | Intentional product use issue | |
| 102932795 | 10293279 | Laser therapy | |
| 102932795 | 10293279 | Pneumonia | |
| 102932795 | 10293279 | Respiratory disorder | |
| 102932795 | 10293279 | Stent placement | |
| 102932795 | 10293279 | Superior vena cava occlusion | |
| 102932795 | 10293279 | Superior vena cava syndrome | |
| 102932795 | 10293279 | Vascular graft |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 102932795 | 10293279 | 1 | 2001 | 0 | ||
| 102932795 | 10293279 | 4 | 2007 | 0 |